BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iskit AB, Guc MO. A new therapeutic approach for the treatment of sepsis. Med Hypotheses 2004;62:342-5. [PMID: 14975500 DOI: 10.1016/j.mehy.2003.11.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Alici O, Kavakli HS, Koca C, Altintas ND, Aydin M, Alici S. Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats. Mediators Inflamm 2015;2015:810948. [PMID: 25948886 DOI: 10.1155/2015/810948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Leite-avalca MC, Lomba LA, Bastos-pereira AL, Brito HO, Fraga D, Zampronio AR. Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats. Shock 2016;46:290-6. [DOI: 10.1097/shk.0000000000000598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
3 Erdem A, Meltem Sevgili A, Akbiyik F, Atilla P, Cakar N, Balkanci ZD, Iskit AB, Guc MO. Tezosentan attenuates organ injury and mesenteric blood flow decrease in endotoxemia and cecal ligation and puncture. J Surg Res 2007;141:211-9. [PMID: 17583743 DOI: 10.1016/j.jss.2006.08.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
4 Ozer EK, Goktas MT, Toker A, Bariskaner H, Ugurluoglu C, Iskit AB. Effects of Carvacrol on Survival, Mesenteric Blood Flow, Aortic Function and Multiple Organ Injury in a Murine Model of Polymicrobial Sepsis. Inflammation 2017;40:1654-63. [DOI: 10.1007/s10753-017-0605-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Escames G, Acuña-Castroviejo D, López LC, Tan DX, Maldonado MD, Sánchez-Hidalgo M, León J, Reiter RJ. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 2006;58:1153-65. [PMID: 16945173 DOI: 10.1211/jpp.58.9.0001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
6 McKenna S, Gossling M, Bugarini A, Hill E, Anderson AL, Rancourt RC, Balasubramaniyan N, El Kasmi KC, Wright CJ. Endotoxemia Induces IκBβ/NF-κB-Dependent Endothelin-1 Expression in Hepatic Macrophages. J Immunol 2015;195:3866-79. [PMID: 26342031 DOI: 10.4049/jimmunol.1501017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
7 Freeman BD, Machado FS, Tanowitz HB, Desruisseaux MS. Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci 2014;118:110-9. [PMID: 24780317 DOI: 10.1016/j.lfs.2014.04.021] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
8 Iskit AB, Senel I, Sokmensuer C, Guc MO. Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock. Eur J Pharmacol 2004;506:83-8. [PMID: 15588628 DOI: 10.1016/j.ejphar.2004.10.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
9 Hwang Y, Park B, Lim J, Kim M, Park S, Hwang M, Yun H. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock. European Journal of Pharmacology 2007;556:166-71. [DOI: 10.1016/j.ejphar.2006.10.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]